Negative / Null Result ReportOpen accessMedicine
Olvert A. Berkhemer, Puck Fransen, Debbie Beumer et al. · 2014 · New England Journal of Medicine
BACKGROUND: In patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion, intraarterial treatment is highly effective for emergency revascularization. However, proof of a beneficial effect on functional…
View details →Negative / Null Result ReportOpen accessMedicine
Els van Nood, Anne Vrieze, Max Nieuwdorp et al. · 2013 · New England Journal of Medicine
BACKGROUND: Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.…
View details →Negative / Null Result ReportOpen accessMedicine
Thomas G. Brott, Robert W. Hobson, George Howard et al. · 2010 · New England Journal of Medicine
BACKGROUND: Carotid-artery stenting and carotid endarterectomy are both options for treating carotid-artery stenosis, an important cause of stroke. METHODS: We randomly assigned patients with symptomatic or asymptomatic carotid stenosis to…
View details →Negative / Null Result ReportOpen accessMedicine
The ACCORD Study Group · 2010 · New England Journal of Medicine
BACKGROUND: We investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for…
View details →Negative / Null Result ReportOpen accessMedicine
Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann et al. · 2014 · New England Journal of Medicine
BACKGROUND: Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction. We evaluated the effects of spironolactone in patients with heart failure and a…
View details →Negative / Null Result ReportOpen accessMedicine
Freddie C. Hamdy, Jenny Donovan, J. Athene Lane et al. · 2016 · New England Journal of Medicine
BACKGROUND: The comparative effectiveness of treatments for prostate cancer that is detected by prostate-specific antigen (PSA) testing remains uncertain. METHODS: We compared active monitoring, radical prostatectomy, and external-beam…
View details →Negative / Null Result ReportMedicine
John B. Holcomb, Barbara C. Tilley, Sarah Baraniuk et al. · 2015 · JAMA
IMPORTANCE: Severely injured patients experiencing hemorrhagic shock often require massive transfusion. Earlier transfusion with higher blood product ratios (plasma, platelets, and red blood cells), defined as damage control resuscitation,…
View details →Negative / Null Result ReportOpen accessMedicine
Joseph P. Broderick, Yuko Y. Palesch, Andrew M. Demchuk et al. · 2013 · New England Journal of Medicine
BACKGROUND: Endovascular therapy is increasingly used after the administration of intravenous tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic stroke, but whether a combined approach is more effective…
View details →Negative / Null Result ReportOpen accessMedicine
G. Michael Felker, Kerry L. Lee, David A. Bull et al. · 2011 · New England Journal of Medicine
BACKGROUND: Loop diuretics are an essential component of therapy for patients with acute decompensated heart failure, but there are few prospective data to guide their use. METHODS: In a prospective, double-blind, randomized trial, we…
View details →Negative / Null Result ReportOpen accessMedicine
John Myburgh, Simon Finfer, Rinaldo Bellomo et al. · 2012 · New England Journal of Medicine
BACKGROUND: The safety and efficacy of hydroxyethyl starch (HES) for fluid resuscitation have not been fully evaluated, and adverse effects of HES on survival and renal function have been reported. METHODS: We randomly assigned 7000…
View details →Negative / Null Result ReportOpen accessMedicine
The HPS2-THRIVE Collaborative Group · 2014 · New England Journal of Medicine
BACKGROUND: Patients with evidence of vascular disease are at increased risk for subsequent vascular events despite effective use of statins to lower the low-density lipoprotein (LDL) cholesterol level. Niacin lowers the LDL cholesterol…
View details →Negative / Null Result ReportMedicine
Brad H. Rovin, Richard Furie, Kevin Latinis et al. · 2012 · Arthritis & Rheumatism
OBJECTIVE: To evaluate the efficacy and safety of rituximab in a randomized, double-blind, placebo-controlled phase III trial in patients with lupus nephritis treated concomitantly with mycophenolate mofetil (MMF) and corticosteroids.…
View details →Negative / Null Result ReportOpen accessMedicine
Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · 2022 · The Journal of Prevention of Alzheimer s Disease
BACKGROUND: Alzheimer's disease is a progressive, irreversible, and fatal disease for which accumulation of amyloid beta is thought to play a key role in pathogenesis. Aducanumab is a human monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta. OBJECTIVES: We evaluated the efficacy and safety of aducanumab in early Alzheimer's disease. DESIGN: EMERGE and ENGAGE were two randomized, double-blind, placebo-controlled, global, phase 3 studies of aducanumab in patients with early Alzheimer's disease. SETTING: These studies involved 348 sites in 20 countries. PA
View details →Negative / Null Result ReportOpen accessMedicine
Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · 2020 · JAMA
Importance: Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate disease is unknown. Objective: To determine the…
View details →Negative / Null Result ReportOpen accessMedicine
Marie Bakitas, Tor D. Tosteson, Zhigang Li et al. · 2015 · Journal of Clinical Oncology
PURPOSE: Randomized controlled trials have supported integrated oncology and palliative care (PC); however, optimal timing has not been evaluated. We investigated the effect of early versus delayed PC on quality of life (QOL), symptom…
View details →Negative / Null Result ReportOpen accessMedicine
Pierre Asfar, Ferhat Meziani, Jean‐François Hamel et al. · 2014 · New England Journal of Medicine
BACKGROUND: The Surviving Sepsis Campaign recommends targeting a mean arterial pressure of at least 65 mm Hg during initial resuscitation of patients with septic shock. However, whether this blood-pressure target is more or less effective…
View details →Negative / Null Result ReportOpen accessMedicine
Domenica A. Delgado, Bradley S. Lambert, Nickolas Boutris et al. · 2018 · JAAOS Global Research and Reviews
Background: The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between “no pain” and “worst pain.”…
View details →Negative / Null Result ReportOpen accessMedicine
G. L. Andriole, E. David Crawford, Robert L. Grubb et al. · 2012 · JNCI Journal of the National Cancer Institute
BACKGROUND: The prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was undertaken to determine whether there is a reduction in prostate cancer mortality from screening using serum…
View details →Negative / Null Result ReportOpen accessMedicine
Martín Cowie, Holger Woehrle, Karl Wegscheider et al. · 2015 · New England Journal of Medicine
BACKGROUND: Central sleep apnea is associated with poor prognosis and death in patients with heart failure. Adaptive servo-ventilation is a therapy that uses a noninvasive ventilator to treat central sleep apnea by delivering…
View details →Negative / Null Result ReportMedicine
Nicholas J. Robert, Véronique Dièras, John A. Glaspy et al. · 2011 · Journal of Clinical Oncology
PURPOSE: This phase III study compared the efficacy and safety of bevacizumab (BV) when combined with several standard chemotherapy regimens versus those regimens alone for first-line treatment of patients with human epidermal growth…
View details →Negative / Null Result ReportOpen accessMedicine
Carlos A. Morillo, José Antônio Marin‐Neto, Álvaro Avezum et al. · 2015 · New England Journal of Medicine
BACKGROUND: The role of trypanocidal therapy in patients with established Chagas' cardiomyopathy is unproven. METHODS: We conducted a prospective, multicenter, randomized study involving 2854 patients with Chagas' cardiomyopathy who…
View details →Negative / Null Result ReportOpen accessMedicine
Vivek Y. Reddy, Shephal K. Doshi, Saibal Kar et al. · 2017 · Journal of the American College of Cardiology
BACKGROUND: The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, St.…
View details →Negative / Null Result ReportOpen accessMedicine
Robert Gottlieb, Ajay Nirula, Peter Chen et al. · 2021 · JAMA
Importance: Coronavirus disease 2019 (COVID-19) continues to spread rapidly worldwide. Neutralizing antibodies are a potential treatment for COVID-19. Objective: To determine the effect of bamlanivimab monotherapy and combination therapy…
View details →Negative / Null Result ReportOpen accessMedicine
P.J. Devereaux, Marko Mrkobrada, Daniel I. Sessler et al. · 2014 · New England Journal of Medicine
BACKGROUND: There is substantial variability in the perioperative administration of aspirin in patients undergoing noncardiac surgery, both among patients who are already on an aspirin regimen and among those who are not. METHODS: Using a…
View details →Negative / Null Result ReportOpen accessMedicine
Paulina Salminen, Mika Helmiö, Jari Ovaska et al. · 2018 · JAMA
Importance: Laparoscopic sleeve gastrectomy for treatment of morbid obesity has increased substantially despite the lack of long-term results compared with laparoscopic Roux-en-Y gastric bypass. Objective: To determine whether laparoscopic…
View details →Negative / Null Result ReportOpen accessMedicine
Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis et al. · 2010 · Journal of Clinical Oncology
PURPOSE: The combination of gemcitabine plus bevacizumab produced a 21% response rate and a median survival of 8.8 months in a multicenter phase II trial in patients with metastatic pancreatic cancer. These encouraging data led Cancer and…
View details →Negative / Null Result ReportOpen accessMedicine
Antoni Ribas, Richard Kefford, Margaret Marshall et al. · 2013 · Journal of Clinical Oncology
PURPOSE: In phase I/II trials, the cytotoxic T lymphocyte-associated antigen-4-blocking monoclonal antibody tremelimumab induced durable responses in a subset of patients with advanced melanoma. This phase III study evaluated overall…
View details →Negative / Null Result ReportMedicine
Mark R. Thursz, Paul Richardson, Michael Allison et al. · 2015 · New England Journal of Medicine
BACKGROUND: Alcoholic hepatitis is a clinical syndrome characterized by jaundice and liver impairment that occurs in patients with a history of heavy and prolonged alcohol use. The short-term mortality among patients with severe disease…
View details →Negative / Null Result ReportMedicine
Katrina L. Salazar, Haijun Zhou, Jiaqiong Xu et al. · 2015 · Acta Cytologica
OBJECTIVE: Individuals are often infected with multiple genotypes of human papillomavirus (HPV) simultaneously, but the role these infections play in the development of cervical disease is not well established. This study aimed to…
View details →Negative / Null Result ReportOpen accessMedicine
Friedrich Koehler, Sebastian Winkler, Michael Schieber et al. · 2011 · Circulation
BACKGROUND: This study was designed to determine whether physician-led remote telemedical management (RTM) compared with usual care would result in reduced mortality in ambulatory patients with chronic heart failure (HF). METHODS AND…
View details →